{'fraction_non_alphanumeric': 0.03353630827956012, 'fraction_numerical': 0.022902844678723985, 'mean_word_length': 5.186955299409615, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Klotho Suppresses Cardiomyocyte Apoptosis in Mice with Stress-Induced Cardiac Injury via Downregulation of Endoplasmic Reticulum Stress

Cardiomyocyte apoptosis is a common pathological alteration in heart disease which results in systolic dysfunction or sudden death. Klotho is a novel anti-aging hormone. We tested the effects of klotho on cell apoptosis in isoproterenol-treated cardiomyocytes. In BALB/c mice, cardiac injury was induced by subcutaneous injection of isoproterenol (5mg/kg, for 9days, sc). Klotho (0.01 mg/kg, every other day for 4days, ip) was administered to determine the changes in isoproterenol-induced apoptosis. Mouse heart was harvested at day 2, day 5, and day 9 after isoproterenol injection. Isoproterenol induced cardiac apoptosis and endoplasmic reticulum (ER) stress in a time-dependent manner. However, klotho partly reversed isoproterenol-induced cardiac apoptosis and ER stress. These same effects were observed in cultured cardiomyocytes. Furthermore, the results also showed that SB203580, a p38 inhibitor, and SP600125, a c-Jun NH2-terminal kinase (JNK) inhibitor, reduced cardiomyocyte apoptosis and ER stress, however, klotho suppressed isoproterenol-induced activation of p38 and JNK. Taken together, these results indicated that cardioprotection by klotho was related to the attenuation of ER stress and ER stress-induced apoptosis, at least partly, through suppressing activation of the p38 and JNK pathway.


Introduction
Regardless of etiology, cardiac remodeling is a common pathological alteration in terms of structure and function in response to various pathogenic stimuli including chronic pressure overload (e.g. essential hypertension), chronic volume overload (e.g. valvular regurgitation), and myocardial infarction [1]. Cardiomyocyte apoptosis plays a key role in the process of remodeling and results in systolic dysfunction or sudden death [2]. Endoplasmic reticulum (ER) is a key participant in cellular apoptosis in response to stress, and disruption of ER homeostasis in response to several pathological stresses activates the ER stress signal and subsequently induces apoptosis when adaptive response fails to alleviate the stress [3][4][5].
Many studies have shown that severe ER stress results in cardiomyocyte apoptosis in vivo and in vitro [3,6]. Inhibitors of ER stress can protect the heart from pathological changes including apoptosis [7,8]. Reports demonstrate that upregulation of ER chaperone proteins and subsequent transcription induction of pro-apoptosis transcription factor CCAAT/enhancer-binding protein homologous protein (CHOP / GADD153) are involved in ER stress-mediated apoptosis induced by pathogenic stimuli including isoproterenol (ISO) in cultured cardiomyocytes [3,[9][10][11]. CHOP is critical in ER stress-induced apoptosis, and CHOP deficiency inhibits apoptosis [12].The progress of ER stress is initiated by the dissociation of signaling molecules from the abundant chaperone BiP/GRP78 in ER lumen [13]; a prolonged ER stress signal can eventually induce the expression of pro-apoptosis CHOP [14,15]. HSP47 is another ER-resident chaperone, and increased HSP47 also plays an important role in CHOPmediated apoptosis [16].
Cells regulate intracellular signal pathways in response to exogenous stimuli. Mitogen-activated protein kinases (MAPK), an ubiquitous intracellular signal, consisting of extracellular signal regulated kinase 1/2 (ERK1/2), p38 and c-Jun NH2terminal kinase (JNK), regulates cellular proliferation, differentiation and apoptosis, and also plays an important regulatory role in ER stress-induced apoptosis [14,17,18]. Therefore, we may assume that endogenous factors which suppress the activation of MAPK and ER stress could decrease cardiomyocyte apoptosis and ameliorate cardiac remodeling.
Klotho exerts anti-aging effects, and klotho deficiency results in multiple age-related disorders closely resembling human aging, including atherosclerosis, ectopic calcification and shortened lifespan [19]. The klotho gene encodes a single-pass transmembrane protein predominantly expressed in renal tissue. In addition, the extracellular domain of klotho is shed and released into circulation known as secreted klotho [19,20]. Accumulative evidence indicates that secreted klotho exerts resistance to oxidative stress and inflammation via regulation of intracellular signal pathways including p38 MAPK [21,22]. In addition, klotho-deficient mice develop exaggerated remodeling and apoptosis in response to ISO treatment, suggesting a cardioprotective effect by klotho [23]. However, the link between klotho and the ER stress-driven apoptotic signal has not been elucidated.
Cardiac remodeling induced by ISO injection is a wellestablished model [24]. We designed the present study to determine whether klotho alleviated ISO-induced cardiac remodeling. We also investigated the protective effect of klotho on ER stress and subsequent apoptosis regulated by the MAPK signaling pathway.

Animal experiments
Male 6-to 8-week-old BALB/c mice (20-25g) were randomly assigned to one of the following groups. The CON group (n=18) received subcutaneous injections of saline (0.1 mL, per day for 9 days) and intraperitoneal injections of saline (0.1 mL, every other day for 4 days); the ISO group (n=17) received subcutaneous injections of ISO (5 mg/kg, dissolved in 0.1 mL saline, per day for 9 days) and intraperitoneal injections of saline (0.1 mL, every other day for 4 days); the ISO+KL group (n=18) received intraperitoneal injections of recombinant klotho protein (0.01 mg/kg, dissolved in 0.1 mL saline, every other day for 4days) plus the daily injections of ISO as above [25,26]. The mice were euthanized at day2, day5 and day9 after ISO treatment. All efforts were made to ameliorate suffering of animals.

Tissue preparation and histological analyses
The hearts were carefully excised, washed in cold PBS and freed of connective tissue at day 2, day 5 and day 9 respectively. Each heart was weighed (HW), and HW was normalized by body weigh (HW/BW Ratio). Each heart was cut into six blocks, three blocks were stored in liquid nitrogen for Real-time PCR and western blot assay. The remaining blocks from LV were fixed in 4% formaldehyde for 24 hours and embedded in paraffin. Serial sections of 4 um were stained with hematoxylin/eosin (HE) for morphologic analysis. For collagen quantification, serial sections were also stained with Masson's trichrome. Images were captured with a Leica microscope (Leica DMI3000 B). The collagen volume fraction (CVF) was determined (the ratio of interstitial collagen area to myocardial area) by Image-Pro Plus 6.0 ( IPP 6.0, Media Cybernetics, MD, USA) for an average of 10 micrographs [27].

Terminal transferase-mediated dUTP nick-end labeling (TUNEL) assays
For the analysis of cardiac apoptosis, TUNEL assay was performed according to the specifications for in situ apoptosis detection kit. Micrographs were obtained using a Leica microscope (Leica DMI3000 B). To determine the apoptosis rate, 10 random fields from each section were quantified in a blinded manner. The total cell numbers in each section were about 2000. Three sections per group were used [28].

In situ detection of ROS production
Oxidative stress in myocardium was determined by detecting the ROS production in situ by dihydroethidium (DHE, Biotype Biotechnology). Fluorescence images were obtained using a fluorescence microscope (Olympus, Japan) equipped with a rhodamine filter [29].

Immunohistochemistry
Paraffin-embedded cardiac sections were dewaxed, and then washed in Tris-buffered saline (TBS) containing 3% bovine serum albumin (BSA). Endogenous peroxidase activity was quenched by 3% H 2 O 2 in methanol. These sections were incubated with anti-GRP78, anti-HSP47 and anti-CHOP (diluted 1:100), and developed with corresponding kit. The cell nuclei were counterstained with hematoxylin. The optical densities were quantified by IPP 6.0 at 10 randomly-selected fields per sample. Three sections per group were used.

Quantitative real-time PCR analysis
Total RNA was extracted from frozen myocardial tissues using Trizol. Ultramicro-ultraviolet spectrophotometry (Beckman) was used to measure the concentration and purity. A ReverTra Ace® qPCR RT Kit was used for reverse transcription. A SYBR® green real-time PCR Master Mix-Plu

Cell culture
It has been reported that the H9c2 cell line (embryonic rat heart derived) is an ideal model for in vitro studies of cardiac injury as it shows almost identical pathological responses to those observed in primary cardiomyocytes [30]. H9c2 cells were purchased from the Cell Bank of Chinese Academy of Science (Shanghai, China), and grown in DMEM containing 10% fetal bovine serum (FBS).

Cell apoptosis assay
To determine the effect of different treatments on apoptosis, H9c2 cells were plated in 6-well plates and treated with arranged stimuli. Apoptotic cells were measured using a PI/ Annexin V-FITC kit on a FACScan flow cytometer (Becton Dickinson, Mountain View, CA).

Intracellular ROS production
H9c2 cells were plated in 6-well plates. Treatment was terminated with ice-cold PBS and then incubated with 5uM DCF-DA. The DCF fluorescence intensity was measured on a FACScan flow cytometer using 485 nm excitation and 535 nm emission filters.

Statistical analysis
SPSS (version 13.0) was used for statistical analyses. All experiments were repeated at least three times. Data are the mean±SEM. Groups of data were compared with ANOVA, followed by Tukey's multiple comparison tests. Data that did not follow a normal distribution were analysed with the Mann-Whitney test or Student's t-test after log normalization. P <0.05 was considered significant.

1: Klotho inhibited ISO-induced pathological changes in mouse heart
We detected the overall circulating level of klotho in serum and found that it was significantly increased after administration of recombinant klotho ( Figure S1). To determine whether klotho could inhibit pathological changes in mouse with ISO-induced cardiac injury, a mouse model of cardiac remodeling was induced following subcutaneous injection of ISO for 9 days. We observed cardiac histological difference between ISO group and ISO+KL group at day 2, day 5 and day 9. In the control group, myocardial fibers were arranged regularly. However, histological sections of mouse heart showed disordered arrangement of myocardial fibers, abundant fibroblastic hyperplasia evidentiated by an increase in the nuclei density and a few of focal mononuclear cell infiltration after ISO injection, indicating serious pathological changes in ISO group ( Figure 1A). However, klotho ameliorated these changes during the same period, suggesting a cardioprotective effect by klotho ( Figure 1A). Masson trichrome staining showed significantly increased interstitial and perivascular fibrosis in ISO group from day 5 compared with CON group, and klotho partly reduced cardiac fibrosis from day 5 compared with ISO group ( Figure  1B, C, D). These results suggested that klotho inhibited ISOinduced structural changes in mouse heart.

2: Klotho reduced ISO-induced apoptosis in mouse heart
Apoptosis plays a major role in myocardial remodeling and causes cardiac dysfunction via cardiomyocytes loss. In addition, oxidative stress is an important regulator of apoptosis. So we detected the effects of klotho on apoptosis and ROS production in mouse heart. Results showed that ISO significantly increased the percentage of TUNEL-positive cells compared with CON group at day 9. (Figure 2A, Figure  S2).Administration of klotho significantly reduced the percentage of TUNEL-positive cells at day 9 although it did not reduce it at day 2 and day 5 (Figure 2A, Figure S2), indicating the chronic supplement of klotho could inhibit apoptosis. In accordance with these results, ROS were significantly stimulated in ISO group, but were abated in ISO+KL group ( Figure 2B,C).

3: Klotho inhibited the ER stress-induced apoptotic signal in mouse heart
To further determine the effect of klotho on the apoptotic signal, we detected the expression of ER stress biomarker (GRP78, HSP47) and ER stress-related pro-apoptosis factor (CHOP) in different groups. Immunohistochemical staining for GRP78 showed that ISO statistically increased the expression of GRP78 from day 5 compared with CON group. Klotho did not significantly decrease the expression of GRP78 at earlier stage (day2,day5), but it succeed at day9 (Figure 3A,B).
Immunohistochemical staining for HSP47 showed that the expression of HSP47 in ISO group was statistically higher than in CON group from day2 to day9. Klotho markedly decreased the expression of HSP47 from day2 to day9 ( Figure 4A,B). Results also showed that the expression of CHOP in ISO group was higher than in CON group from day2 to day9. Importantly, klotho statistically decreased the expression of CHOP at day 9 ( Figure 5A, B). Western blotting for GRP78, HSP47, and CHOP also showed identical results ( Figure 6A, B). Real-time PCR for GRP78, HSP47, and CHOP showed dramatic increases in mRNA levels of ER stress markers in ISO group, but it was partially attenuated in ISO+KL group ( Figure 7A, B, C). Thus, ISO-induced sustained ER stress and apoptosis in mouse heart were partly prevented by klotho.

4: Klotho reduced ISO-induced apoptosis in H9c2 cells
The above in vivo studies clearly indicated an inhibitory effect by klotho on ISO-induced cardiac apoptosis. In vitro study showed that there was a dose-dependent increase in cell apoptosis following exposure of H9c2 cells to ISO ( Figure  8A,B). As a study demonstrated the induction of apoptotic cell death by ISO at the concentration of 10 uM in H9c2 cells [31], we selected 10 uM in our subsequent study. To determine the effect of klotho on apoptosis in cultured cells, we treated H9c2 cells with ISO and/or klotho. Results showed that klotho statistically reduced ISO-induced apoptosis ( Figure 8C, D). We also found that ISO stimulated ROS production, which were    partly prevented by klotho ( Figure 8E,F). These results indicated the klotho's anti-apoptosis property.

5: Klotho inhibited apoptosis through the amelioration of ER stress in H9c2 cells
In the present study, ISO significantly increased the expression of GRP78, HSP47 and CHOP, suggesting the activation of ER stress and ER stress-related apoptotic signal ( Figure 9A, B, C, D). Pretreatment of H9c2 cells with 1ug/ml of  klotho before exposure to ISO effectively ameliorated these changes although 0.1ug/ml of klotho did not significantly reduce the levels of GRP78 and HSP47 ( Figure 9A, B, C). These results indicated the anti-apoptosis character of klotho was dependent on the inhibition of ER stress.

6: The MAPK pathway was involved in the antiapoptosis effect of klotho
In accordance with the previous results, klotho significantly reduced ISO-induce apoptosis. Pretreatment of cells with SB203580 or SP600125 also induced a marked reduction in apoptosis ( Figure 10A, B). However, PD98059 did not statistically inhibit apoptosis. In addition, the levels of GRP78, HSP47 and CHOP were significantly decreased by klotho, SB203580 and SP600125, but not by PD98059 (Figure 10 C, D, E, F).These results suggested that klotho ameliorated ER stress and ER stress-induced apoptosis through inhibition of the p38 and JNK pathway.
We further determined the direct effect of klotho on MAPK. Results showed that ISO activated the phosphorylation of MAPK in H9c2 cells ( Figure S3A, B, C, D), and addition of klotho (0.01-10ug/ml) did not statistically affect the phosphorylation of ERK1/2 (Figure 11 A, B), but it significantly stimulated the phosphorylation of p38 and JNK at 0.1ug/ml and 1ug/ml respectively ( Figure 11A, C, D). These results indicated anti-apoptosis effect by klotho was partly dependent on suppression of the p38 and JNK pathway.

Discussion
The protective effect of klotho observed in this study included amelioration of the structural changes in mouse heart. More importantly, klotho inhibited cell apoptosis in vivo and in vitro, which was, at least partly, attributed to suppression of the ER stress-induced apoptotic signal. However, specific p38 and JNK inhibitors (SB203580 and SP600125) efficiently suppressed ER stress and subsequent apoptosis. Moreover, klotho partly inhibited phosphorylation of the p38 and JNK pathway in H9c2 cells. so we concluded that klotho inhibited ISO-induced ER stress and apoptotic signal through suppression of the P38 and JNK pathway, and finally improved cardiac pathological changes.
H9c2 cells display morphological characteristics similar to those of immature embryonic cardiocytes, and preserve to a large extent the signaling pathways found in adult cardiac cells [32]. Many studies also showed that H9c2 cell line had been extensively used to investigate the pathological process of cardiac hypertrophy and apoptosis. Furthermore, ISO induced the same ER stress in H9c2 cells as in primary cultured cardiomyocytes [3,9,31]. So our study used H9c2 cells as a cardiomyocyte apoptosis model to investigate the effect of klotho on ER stress-induced apoptosis.
Klotho was reported to resist oxidative stress at both organism and cellular level in mammals, which might potentially contribute to its anti-aging property [33].Recently, many studies showed that klotho reduced apoptosis and oxidative stress via regulation of the signal pathways in endothelial cells [34]. Clinical studies also showed that a decreased level of serum klotho might be an early biomarker for chronic kidney disease-induced cardiovascular disorder [35].However, studies on the cardioprotection of klotho are limited. This study demonstrated that klotho played a protective role in ISO-induced cardiac pathologies, which was supported by another study [23]. Most notably, we also found that klotho inhibited ISO-induced cardiomyocyte apoptosis, which was potentially contributed to amelioration of the ER stress-induced apoptotic signal. So it is reasonable to conclude that amelioration of ER stress might be another new and important effect of klotho.
Increasing evidence has shown that ER is recognized as an important organelle which participates in the apoptotic pathway. ER stress is a common denominator which mediates damaging effect especially apoptosis [10]. Induction of ER chaperone proteins is an early adoptive response to ER stress, and is also a mark of the severity of stress. In this study, we found that klotho down-regulated ER chaperone proteins in response to ISO. In accordance with our finding, it was reported that downregulation of ER chaperone proteins was beneficial in heart apoptosis [36]. Paradoxically, induction of GRP78 by gene transfer or pharmacological agents protected cardiomyocytes from hypoxic injury [37]. The reason for these differences may be that the function of GRP78 depends on the severity of the stress or the difference in stimulatory conditions. In the early stage of ER stress, compensatory induction of GRP78 ameliorated ER stress and inhibited apoptosis. But prolonged or excessive ER stress induced GRP78 and resulted in apoptosis. HSP47 is also a ER chaperone, and disturbance of HSP47 induces CHOP-dependent apoptosis [38].Thus, these results suggest two possible roles for klotho: klotho ameliorated ER stress and subsequently reduces the expression of GRP78 and HSP47 or klotho reduced the expression of GRP78 and HSP47 without inhibiting ER stress-induced apoptosis. Transcription factor CHOP is an important ER stress-mediated pro-apoptosis factor, which plays a critical role in myocardial apoptosis [14].We found that klotho reduced the expression of CHOP, therefore it was reasonable to assume that the reduction of ER chaperone proteins was due to ER stress inhibition. We also found that klotho inhibited ROS production in mouse heart and H9c2 cells. In brief, these data indicated that the anti-apoptosis effect of klotho was partially attributed to the amelioration of ER stress and oxidative stress. The MAPK pathway played important roles in cardiac apoptosis. Dominant-negative or constitutively activated forms of the p38 MAPK and ERK1/2 signaling pathways demonstrated that activation of p38 MAPK or inhibition of ERK1/2 were critical for induction of apoptosis in many cells, including cardiomyocytes [39]. Studies demonstrated that inhibition of ERK1/2 enhanced ischemia/reoxygenationinduced apoptosis and phenylephrine-induced hypertrophy in cardiomyocytes [40]. Inhibition of p38 MAPK and JNK efficiently attenuated cardiac remodeling [41]. Therefore, the dynamic balance between growth factor-activated ERK1/2 and stressactivated p38 and JNK is important in determining a cell's fate. Evidence indicated the involvement of ERK1/2, p38 and JNK in ER stress-induced apoptosis in cardiomyocytes [42,43]. More recently, it was demonstrated that inhibition of p38 MAPK with the dominant-negative form efficiently reduced CHOPmediated myocardial apoptosis [14]. In our study, SB203580 and SP600125 statistically inhibited ISO-induced ER stress and apoptosis, however, the PD98059 only slightly inhibited it. In accordance, klotho significantly inhibited ISO-induced phosphorylation of p38 and JNK, but did not remarkably effect the phosphorylation of ERK1/2 at each dose, indicating a better response to p38 and JNK . Therefore, it is reasonable to conclude that klotho suppresses apoptosis partially through inhibition of the p38 and JNK pathway.
In conclusion, this study demonstrated that klotho effectively suppressed ISO-induced histological changes in mouse heart. Importantly, klotho played a pivotal role in inhibiting ISOinduced cardiomyocyte apoptosis in vivo and in vitro, and these effects were associated with amelioration of the ER stressinduced apoptosis signal through inhibition of the P38 and JNK pathway. In addition to uncovering a new action of klotho, these results could be clinically relevant for the treatment of heart failure.